These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 10943109
1. [Potentials of screening for Chlamydia trachomatis in Hungary: cost-benefit analysis]. Nyári T, Mészáros G, Deák J, Nagy E, Kovács L. Orv Hetil; 2000 Jul 02; 141(27):1511-6. PubMed ID: 10943109 [Abstract] [Full Text] [Related]
2. Universal screening or prophylactic treatment for Chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective? Chen S, Li J, van den Hoek A. Sex Transm Dis; 2007 Apr 02; 34(4):230-6. PubMed ID: 17414068 [Abstract] [Full Text] [Related]
3. Risk assessment and other screening options for gonorrhoea and chlamydial infections in women attending rural Tanzanian antenatal clinics. Mayaud P, Grosskurth H, Changalucha J, Todd J, West B, Gabone R, Senkoro K, Rusizoka M, Laga M, Hayes R. Bull World Health Organ; 1995 Apr 02; 73(5):621-30. PubMed ID: 8846488 [Abstract] [Full Text] [Related]
4. Screening for Chlamydia trachomatis in asymptomatic women in Hungary. An epidemiological and cost-effectiveness analysis. Nyári T, Nyári C, Woodward M, Mészáros G, Deák J, Nagy E, Kovács L. Acta Obstet Gynecol Scand; 2001 Apr 02; 80(4):300-6. PubMed ID: 11264602 [Abstract] [Full Text] [Related]
5. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more]. Postma MJ, Bakker A, Welte R, van Bergen JE, van den Hoek JA, de Jong-van den Berg LT, Jager JC. Ned Tijdschr Geneeskd; 2000 Dec 02; 144(49):2350-4. PubMed ID: 11129971 [Abstract] [Full Text] [Related]
11. Chlamydia trachomatis infection and the risk of perinatal mortality in Hungary. Nyári T, Woodward M, Mészáros G, Karsai J, Kovács L. J Perinat Med; 2001 Dec 02; 29(1):55-9. PubMed ID: 11234618 [Abstract] [Full Text] [Related]
12. Evaluating adolescents in juvenile detention facilities for urogenital chlamydial infection: costs and effectiveness of alternative interventions. Mrus JM, Biro FM, Huang B, Tsevat J. Arch Pediatr Adolesc Med; 2003 Jul 02; 157(7):696-702. PubMed ID: 12860793 [Abstract] [Full Text] [Related]
13. [Chlamydia trachomatis: should it be systematically be screened or treated? Literature review and cost/benefit estimation in France]. Henry-Suchet J, Sluzhinska A, Serfaty D. Contracept Fertil Sex; 1998 Feb 02; 26(2):151-8. PubMed ID: 9560916 [Abstract] [Full Text] [Related]
14. [Chlamydia trachomatis in pregnant women in the county of Vestsjaelland. Prevalence, prevention of perinatal transmission and cost-effectiveness of screening]. Ottesen M, Sahl I, Herbstman MM, Friis HM, Philipsen T. Ugeskr Laeger; 1996 Feb 05; 158(6):756-8. PubMed ID: 8638313 [Abstract] [Full Text] [Related]
15. A Swedish cost-effectiveness analysis of community-based Chlamydia trachomatis PCR testing of postal urine specimens obtained at home. Novak DP, Lindholm L, Jonsson M, Karlsson RB. Scand J Public Health; 2004 Feb 05; 32(5):324-32. PubMed ID: 15513664 [Abstract] [Full Text] [Related]
17. Effectiveness and efficiency of selective vs universal screening for chlamydial infection in sexually active young women. Sellors JW, Pickard L, Gafni A, Goldsmith CH, Jang D, Mahony JB, Chernesky MA. Arch Intern Med; 1992 Sep 05; 152(9):1837-44. PubMed ID: 1520050 [Abstract] [Full Text] [Related]